sumatriptan has been researched along with Cephalgia Syndromes in 15 studies
Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Migraine is a very common disorder." | 2.42 | [Pitfall in migraine treatment]. ( Araki, N, 2003) |
| "Headache disorders are highly prevalent and debilitating, with limited treatment options." | 1.56 | Low-dose interleukin-2 reverses behavioral sensitization in multiple mouse models of headache disorders. ( Cao, YQ; Cloud, ME; Czerpaniak, K; Hotchkiss, RS; Huang, L; Li, D; Liu, X; Unsinger, J; Zhang, J, 2020) |
| "41." | 1.46 | Clinical characteristics and overuse patterns of medication overuse headache: Retrospective case-series study. ( Kluonaitis, K; Petrauskiene, E; Ryliskiene, K, 2017) |
| "Among migraineurs, triptan consumers reported more frequent and severe headaches than non-consumers, and reported a higher incidence of nausea and vomiting." | 1.32 | Use and misuse of triptans in France: data from the GRIM2000 population survey. ( Auray, JP; Chazot, G; Dartigues, JF; Duru, G; El Hasnaoui, A; Gaudin, AF; Henry, P; Lantéri-Minet, M; Lucas, C; Pradalier, A, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 8 (53.33) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, J | 1 |
| Czerpaniak, K | 1 |
| Huang, L | 1 |
| Liu, X | 1 |
| Cloud, ME | 1 |
| Unsinger, J | 1 |
| Hotchkiss, RS | 1 |
| Li, D | 1 |
| Cao, YQ | 1 |
| Kluonaitis, K | 1 |
| Petrauskiene, E | 1 |
| Ryliskiene, K | 1 |
| Moye, LS | 1 |
| Tipton, AF | 1 |
| Dripps, I | 1 |
| Sheets, Z | 1 |
| Crombie, A | 1 |
| Violin, JD | 1 |
| Pradhan, AA | 1 |
| Rapoport, AM | 1 |
| Carpay, JA | 1 |
| Linssen, WH | 1 |
| Koehler, PJ | 1 |
| Arends, LR | 1 |
| Tiedink, HG | 1 |
| Lucas, C | 1 |
| Auray, JP | 1 |
| Gaudin, AF | 1 |
| Dartigues, JF | 1 |
| Duru, G | 1 |
| Henry, P | 1 |
| Lantéri-Minet, M | 1 |
| Pradalier, A | 1 |
| Chazot, G | 1 |
| El Hasnaoui, A | 1 |
| Araki, N | 1 |
| Søndergaard, J | 1 |
| Foged, A | 1 |
| Kragstrup, J | 1 |
| Gaist, D | 1 |
| Gram, LF | 1 |
| Sindrup, SH | 1 |
| Muckadell, HU | 1 |
| Larsen, BO | 1 |
| Herborg, H | 1 |
| Andersen, M | 1 |
| Prusiński, A | 1 |
| Rothner, AD | 1 |
| Evers, S | 1 |
| Husstedt, IW | 1 |
| Cady, R | 1 |
| Evans, RW | 1 |
| Robbins, L | 1 |
| Goadsby, PJ | 1 |
| Akerman, S | 1 |
| Storer, RJ | 1 |
5 reviews available for sumatriptan and Cephalgia Syndromes
| Article | Year |
|---|---|
New acute treatments for headache.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Botulinum Toxins, Type A; Clinical Trials as Topic; Diclofe | 2010 |
[Pitfall in migraine treatment].
Topics: Contraindications; Headache Disorders; Humans; Meta-Analysis as Topic; Migraine Disorders; Randomize | 2003 |
[Drug rebound headaches].
Topics: Adult; Analgesics; Antidepressive Agents; Antidepressive Agents, Tricyclic; Drug Administration Sche | 1999 |
Headaches in children and adolescents: update 2001.
Topics: Adolescent; Analgesics; Arnold-Chiari Malformation; Child; Diagnosis, Differential; Female; Headache | 2001 |
Efficacy of sumatriptan in chronic paroxysmal hemicrania.
Topics: Adult; Chronic Disease; Female; Headache Disorders; Humans; Middle Aged; Serotonin Receptor Agonists | 1998 |
2 trials available for sumatriptan and Cephalgia Syndromes
| Article | Year |
|---|---|
Efficacy of sumatriptan nasal spray in recurrent migrainous headache: an open prospective study.
Topics: Administration, Inhalation; Adult; Female; Headache Disorders; Humans; Male; Migraine Disorders; Pro | 2003 |
Intensive community pharmacy intervention had little impact on triptan consumption: a randomized controlled trial.
Topics: Adult; Denmark; Drug Prescriptions; Drug Utilization; Education, Pharmacy, Continuing; Female; Heada | 2006 |
8 other studies available for sumatriptan and Cephalgia Syndromes
| Article | Year |
|---|---|
Low-dose interleukin-2 reverses behavioral sensitization in multiple mouse models of headache disorders.
Topics: Animals; Headache Disorders; Interleukin-2; Mice; Migraine Disorders; Nitroglycerin; Sumatriptan | 2020 |
Clinical characteristics and overuse patterns of medication overuse headache: Retrospective case-series study.
Topics: Adult; Analgesics; Analgesics, Opioid; Female; Headache Disorders; Headache Disorders, Secondary; Hu | 2017 |
Delta opioid receptor agonists are effective for multiple types of headache disorders.
Topics: Animals; Benzamides; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Headache Diso | 2019 |
Use and misuse of triptans in France: data from the GRIM2000 population survey.
Topics: Adult; Chi-Square Distribution; Female; France; Headache Disorders; Health Surveys; Humans; Male; Mi | 2004 |
Headache due to antimigraine 5HT1 receptor agonists.
Topics: Analgesics; Headache; Headache Disorders; Humans; Indoles; Oxazolidinones; Piperidines; Prospective | 1999 |
Looking forward: the expanding utility of sumatriptan and naratriptan.
Topics: Headache Disorders; Humans; Indoles; Migraine Disorders; Piperidines; Primary Health Care; Serotonin | 2001 |
Daily triptans for headache.
Topics: Drug Administration Schedule; Female; Headache Disorders; Humans; Middle Aged; Serotonin Receptor Ag | 2001 |
Evidence for postjunctional serotonin (5-HT1) receptors in the trigeminocervical complex.
Topics: Animals; Brain; Cats; Cervical Plexus; Electric Stimulation; Ergonovine; Excitatory Amino Acid Agoni | 2001 |